Braveheart Bio, Inc. (BRVE)
NASDAQ · Manufacturing · Pharmaceutical preparations
BRVE price, last 12 months
Key stats
- Previous close
- $18.53
- Open
- $18.68
- Day range
- $18.24 – $19.50
- 52-week range
- $16.70 – $32.00
- Volume
- 1.1M
- Avg volume (20 days)
- 529.9K
- Market cap
- $1.8B
Performance
Technicals and fundamentals
About Braveheart Bio, Inc.
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.8B